Joe Fiandra Access to Home Infusion Act of 2023
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Joe Fiandra Access to Home Infusion Act of 2023 is a House bill introduced in the 118th Congress aimed at addressing issues related to home infusion therapy. The bill was referred to the Subcommittee on Health but did not advance further and ultimately failed or expired. There is no official summary or full text available for this bill, limiting detailed analysis of its provisions. The bill falls under the health policy area and appears to focus on improving access to home infusion services, which typically involve administering medications intravenously in a patient's home setting.
This bill sought to improve access to home infusion therapy but did not progress beyond subcommittee referral and expired without enactment.
- The bill is titled the Joe Fiandra Access to Home Infusion Act of 2023 and was introduced in the House of Representatives during the 118th Congress.
- It was referred to the Subcommittee on Health on December 17, 2024, but no further legislative action was recorded.
- No official summary or full text is publicly available, limiting detailed understanding of the bill's specific provisions or mechanisms.
['Patients requiring home infusion therapy', 'Healthcare providers specializing in home infusion services', 'Health insurers and Medicare/Medicaid programs if related to coverage', 'Subcommittee on Health and related health policy stakeholders']
['Lack of publicly available full text and summary limits transparency and understanding of implementation details.', 'Potential costs and funding mechanisms for expanding home infusion access are unknown.', 'Oversight and enforcement provisions cannot be assessed due to missing text.', 'Unclear authority or regulatory changes that the bill might have proposed.']
The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health but did not advance further, resulting in failure or expiration. The legislative context suggests it was part of ongoing efforts to address healthcare delivery improvements, specifically in home-based care, but it did not receive sufficient legislative traction to proceed.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential increased demand for home infusion services if access were expanded, affecting healthcare providers and supply chains.', 'Possible shifts in healthcare delivery from inpatient to home settings, impacting hospital utilization rates.', 'Changes in insurance coverage policies related to home infusion therapy, influencing payer systems.']
The absence of an official summary and full text for this bill limits transparency and public understanding, which are critical for effective oversight. The bill's failure to advance beyond subcommittee referral suggests limited legislative support or prioritization. Future efforts to improve home infusion access would benefit from clear, accessible documentation to facilitate stakeholder engagement and policy analysis.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.